ArticleFrontiers in immunology2022

A Potent Neutralizing Nanobody Targeting the Spike Receptor-Binding Domain of SARS-CoV-2 and the Structural Basis of Its Intimate Binding.

Jing Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.